Although compelling data exist to support a link between periodontal disease (PD) and the development of rheumatoid arthritis (RA), cementing the association will require extensive investigative work.1 However, in reviewing the literature of the past 10 years, Elliot D. Rosenstein, MD, director, Institute for Rheumatic and Autoimmune Diseases at Overlook Medical Center, Summit, N.J., and…
Search results for: hip OA
How Celebrities, Senators, Dietary Supplements Muddle Medicine
It’s disheartening to stand by and watch helplessly as your patient dies a slow, painful death. In spring 1990, I had the misfortune of living through such a distressing experience. Strange happenings in New Mexico & Japan Ellen was a bookkeeper in her late 40s, living quietly in suburban Boston. For years, she hid a…
Rheumatology Research Foundation Funding Aids Researcher’s Career
For 30 years, the Rheumatology Research Foundation has been funding research and advancing treatments. During that time, Leonard L. Dragone, MD, PhD, received a Foundation award to help look for new strategies to treat autoimmune and inflammatory diseases in mouse models. Then, he was working as an assistant professor of pediatrics and immunology at the…
2015 ACR/ARHP Annual Meeting to Offer Coding, Practice Management Sessions
At this year’s ACR/ARHP Annual Meeting in San Francisco, you can take advantage of a variety of sessions designed to address pressing concerns in practice management today. Practice managers, clinicians, office staff and others will enjoy and benefit from hands-on practical sessions and informative panel discussions by top content experts in the field. Here are…
Super-Group Physician Practices Offer Benefits, But Raise Concerns
Rheumatologists worried about the future of their private practices might want to consider jumping onto the super group trend that allows physicians and other providers with similar services to team up to share opportunities and minimize financial burdens. The biggest concern for private practice physicians watching the trend but not yet embracing it is fear…
Ethics Forum: Plagiarism in EMRs Saves Time, But Can Raise Risk of Errors
Case You’ve been asked to see an inpatient for a rheumatologic consultation. After seeing the patient, you enter an initial consult note in the electronic medical record (EMR). The next day, when you write a follow-up note for this patient, you copy part of your assessment and plan from your prior note. Soon after you…
Internal Due Diligence Review Important for Physician Practices
Whether you’re considering selling your practice, growing your practice or maintaining the status quo, it’s important to periodically do a checkup on your internal operations and compliance with the law. It’s always preferable to discover problems within your practice and correct them (if possible) before those issues are discovered by third parties, such as the…
Twitter Is Key Learning, Networking Tool for Rheumatologists
Jonathan Hausmann, MD, a pediatric and adult rheumatology fellow at Beth Israel Deaconess Medical Center and Boston Children’s Hospital, remembers seeing a patient with a red, swollen and tender big toe early in his fellowship and diagnosing his patient with gout. He was happy to be able to help the patient, and he called in…
Rheumatologist, Cyclist Michael Weinblatt, MD, Tours America on Two Wheels
Bonus: Listen to excerpts from our conversation with Dr. Weinblatt. Michael Weinblatt, MD, is the co-director of clinical rheumatology at Brigham and Women’s Hospital in Boston, a professor of medicine at Harvard Medical School, past president of the American College of Rheumatology, and co-director of the ACR Winter Rheumatology Symposium at Snowmass, Colo. Those are…
Tofacitinib Effective for Treating Moderate-to-Severe Chronic Plaque Psoriasis
NEW YORK (Reuters Health)—Tofacitinib is better than placebo (and noninferior to etanercept) for treating patients with moderate-to-severe chronic plaque psoriasis, according to Pfizer’s OPT Compare trial. In an earlier 12-week, phase 2b, dose-ranging trial, the oral JAK inhibitor tofacitinib proved to be more effective than placebo for treating patients with moderate-to-severe plaque psoriasis. Based on…
- « Previous Page
- 1
- …
- 234
- 235
- 236
- 237
- 238
- …
- 323
- Next Page »